SOS1 was identified as a predictive gene for HCC prognosis in association with RAS [31], and a small molecular inhibitor BAY-293 that disrupts SOS1-KRAS interaction blocked RAS activation, leading to potent anti-proliferative effects [32]. Here, KRAS is linked to hepatocellular carcinoma.